Virax Biolabs (UK) Limited in London, W1K 6LX

Description

Data updated on: 01-11-2023

The company referred to as Virax Biolabs (UK) was started on 2021-09-20 as a Private Limited Company. The firm's office can be contacted at London on 20 North Audley Street. If you want to reach this business by post, the zip code is W1K 6LX. The company registration number for Virax Biolabs (UK) Limited is 13630639. The firm's declared SIC number is 64209 meaning Activities of other holding companies n.e.c.. Its most recent filed accounts documents describe the period up to 2022-03-31 and the most current annual confirmation statement was submitted on 2022-09-19.

Concerning this firm, the full scope of director's obligations have so far been met by James F. who was appointed in 2021 in September.

The companies with significant control over this firm are: Virax Biolabs Group Limited owns over 3/4 of company shares. This business can be reached in Grand Cayman at Camana Bay, KY1 - 9009 and was registered as a PSC under the reg no 380440.

Financial data based on annual reports

Profit & Loss
Date of Accounts	2022-03-31	2023-03-31
Currency

Balance Sheet
Cash Bank On Hand		2 516 525
Current Assets	54	2 516 965
Debtors	54	440
Other Debtors	54	440

Other Financial Data
Accrued Liabilities Deferred Income		105 617
Accumulated Amortisation Impairment Intangible Assets		152 709
Additions Other Than Through Business Combinations Intangible Assets		144 244
Administrative Expenses	2 610	969 004
Amortisation Impairment Expense Intangible Assets		152 709
Amounts Owed To Group Undertakings	8 365	3 191 534
Average Number Employees During Period	1	4
Cash Cash Equivalents Cash Flow Value		2 516 525
Creditors	11 029	3 333 242
Fixed Assets	9 163	698
Further Item Cash Flow From Used In Financing Activities Component Net Cash Flows From Used In Financing Activities		-3 183 169
Gain Loss Due To Foreign Exchange Differences Recognised In Profit Or Loss		29 079
Gain Loss In Cash Flows From Change In Creditors Trade Other Payables	-11 029
Gain Loss In Cash Flows From Change In Debtors Trade Other Receivables	54	386
Impairment Loss Intangible Assets		152 709
Increase Decrease In Cash Cash Equivalents Before Foreign Exchange Differences Changes In Consolidation		-2 516 525
Increase From Impairment Loss Recognised In Profit Or Loss Intangible Assets		152 709
Intangible Assets	8 465
Intangible Assets Gross Cost	8 465	152 709
Investments Fixed Assets	698	698
Investments In Subsidiaries	698	698
Issue Equity Instruments	100
Net Cash Generated From Operations	-8 365	522 400
Net Current Assets Liabilities	-10 975	-816 277
Other Creditors	12	24 867
Pension Other Post-employment Benefit Costs Other Pension Costs		1 117
Percentage Class Share Held In Subsidiary		100
Proceeds From Issuing Shares	-100
Profit Loss	-2 610	-969 004
Profit Loss On Ordinary Activities Before Tax	-2 610	-969 004
Purchase Intangible Assets	-8 465	-144 244
Staff Costs Employee Benefits Expense		458 560
Total Assets Less Current Liabilities	-2 510	-815 579
Trade Creditors Trade Payables	2 652	11 224

Company staff

James F.

Role: Director

Appointed: 20 September 2021

Latest update: 17 April 2024

People with significant control

Virax Biolabs Group Limited

Address: 89 Nexus Way Camana Bay, Grand Cayman, KY1 - 9009, United Kingdom

Legal authority Companies Act 2006

Legal form Private Company Limited By Shares Exempt Under Section 60

Country registered Cayman Islands

Place registered Cayman Islands

Registration number 380440

Notified on 21 July 2022

Nature of control:

over 3/4 of shares

James F.

Notified on 20 April 2022

Ceased on 21 July 2022

Nature of control:

1/2 or less of voting rights

Cameron S.

Notified on 20 April 2022

Ceased on 21 July 2022

Nature of control:

1/2 or less of voting rights

Accounts Documents

Account next due date	30 December 2023
Account last made up date	31 March 2022
Confirmation statement next due date	03 October 2023
Confirmation statement last made up date	19 September 2022

Annual Accounts
Start Date For Period Covered By Report	2021-09-20
End Date For Period Covered By Report	2022-03-31
Annual Accounts
Start Date For Period Covered By Report	2022-04-01
End Date For Period Covered By Report	2023-03-31

Virax Biolabs (UK) Limited

General information

Name:

Office Address:

Description

Financial data based on annual reports

Company staff

James F.

Cameron S.

People with significant control

Virax Biolabs Group Limited

James F.

Cameron S.

Accounts Documents

Company filings

Filing category

Search other companies

Services (by SIC Code)

Company Age

Closest Companies - by postcode